FDA-Approved Small Molecules in 2022: Clinical Uses and Their Synthesis
This review describes the recently FDA-approved drugs (in the year 2022). Many of these products contain active moieties that FDA had not previously approved, either as a single ingredient or as part of a combination. These products frequently provide important new therapies for patients with multip...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9695118/ https://www.ncbi.nlm.nih.gov/pubmed/36432728 http://dx.doi.org/10.3390/pharmaceutics14112538 |